Pharos iBio Co., Ltd. (KOSDAQ:388870)
8,510.00
-160.00 (-1.85%)
At close: Feb 13, 2026
Pharos iBio Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 5,382 | 6,360 | 15,588 | 3,812 | 18,812 | 9,807 |
Short-Term Investments | 3,506 | 9,308 | 9,899 | 11,267 | 5,000 | 5,000 |
Cash & Short-Term Investments | 8,888 | 15,668 | 25,487 | 15,079 | 23,812 | 14,807 |
Cash Growth | -48.38% | -38.53% | 69.02% | -36.68% | 60.81% | 228.90% |
Accounts Receivable | 0 | 0 | 0 | 0 | -0 | 0 |
Other Receivables | 92.94 | 142.02 | 176.56 | 195.54 | 48.02 | 55.64 |
Receivables | 92.94 | 142.02 | 176.56 | 195.54 | 48.01 | 55.64 |
Prepaid Expenses | 97.87 | 72.26 | 160.37 | 167.89 | 234.56 | 111.19 |
Other Current Assets | 187.34 | 371.92 | 346.75 | 272.46 | 327.31 | 257.47 |
Total Current Assets | 9,266 | 16,254 | 26,170 | 15,715 | 24,422 | 15,232 |
Property, Plant & Equipment | 2,576 | 2,817 | 3,218 | 2,541 | 2,700 | 1,398 |
Long-Term Investments | -0 | 0 | 0.13 | 0 | -0 | 0 |
Other Intangible Assets | 391.74 | 419.08 | 148.95 | 203.04 | 264.56 | 64.9 |
Other Long-Term Assets | 148.28 | 137.78 | 153.17 | 262.56 | 99.59 | 6.92 |
Total Assets | 12,382 | 19,628 | 29,690 | 18,721 | 27,486 | 16,702 |
Accrued Expenses | 135.02 | 217.38 | 86.3 | 131.83 | 51.55 | 23.31 |
Current Portion of Long-Term Debt | - | - | - | 106.25 | 125 | 325 |
Current Portion of Leases | 147.73 | 82.11 | 177.25 | 154.31 | 151.2 | 8.02 |
Other Current Liabilities | 536.13 | 673.72 | 949.8 | 558.56 | 42,373 | 16,885 |
Total Current Liabilities | 818.88 | 973.21 | 1,213 | 950.95 | 42,700 | 17,241 |
Long-Term Debt | - | - | - | - | 106.25 | 231.25 |
Long-Term Leases | 102.26 | 41.61 | 127.7 | 105.12 | 209.17 | 23.87 |
Pension & Post-Retirement Benefits | - | - | - | - | 259.36 | 47.3 |
Other Long-Term Liabilities | 64.26 | 0 | -0 | 0 | 6.87 | 22.93 |
Total Liabilities | 985.4 | 1,015 | 1,341 | 1,056 | 43,282 | 17,567 |
Common Stock | 6,473 | 6,473 | 6,459 | 5,738 | 2,902 | 967.28 |
Additional Paid-In Capital | 102,155 | 102,155 | 101,927 | 83,576 | 1,307 | 3,260 |
Retained Earnings | -99,981 | -92,332 | -81,771 | -72,913 | -55,997 | -24,454 |
Comprehensive Income & Other | 2,749 | 2,317 | 1,734 | 1,264 | 604.87 | 180.43 |
Total Common Equity | 11,397 | 18,614 | 28,349 | 17,665 | -51,184 | -20,046 |
Shareholders' Equity | 11,397 | 18,614 | 28,349 | 17,665 | -15,796 | -865.04 |
Total Liabilities & Equity | 12,382 | 19,628 | 29,690 | 18,721 | 27,486 | 16,702 |
Total Debt | 249.99 | 123.72 | 304.95 | 365.68 | 591.61 | 588.14 |
Net Cash (Debt) | 8,638 | 15,544 | 25,182 | 14,714 | 23,221 | 14,219 |
Net Cash Growth | -49.36% | -38.27% | 71.15% | -36.64% | 63.31% | 272.15% |
Net Cash Per Share | 667.50 | 1202.85 | 2080.94 | 1656.70 | 4001.05 | 2514.86 |
Filing Date Shares Outstanding | 12.95 | 12.95 | 12.92 | 11.48 | 5.8 | 0.19 |
Total Common Shares Outstanding | 12.95 | 12.95 | 12.92 | 11.48 | 5.8 | 0.19 |
Working Capital | 8,447 | 15,281 | 24,957 | 14,764 | -18,278 | -2,010 |
Book Value Per Share | 880.34 | 1437.79 | 2194.39 | 1539.19 | -8819.20 | -103622.56 |
Tangible Book Value | 11,005 | 18,194 | 28,200 | 17,462 | -51,448 | -20,111 |
Tangible Book Value Per Share | 850.08 | 1405.42 | 2182.86 | 1521.50 | -8864.79 | -103958.01 |
Land | 367 | 367 | 367 | 367 | 367 | 367 |
Buildings | 782.08 | 782.08 | 782.08 | 782.08 | 782.08 | 782.08 |
Machinery | 2,388 | 2,373 | 1,980 | 1,445 | 1,239 | 389.73 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.